Ιmpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer

Ιmpact of sunitinib-induced hypothyroidism on survival of patients with metastatic renal cancer

Abstract Background Sunitinib plays an important role in managing the metastatic renal cell cancer (mRCC). Sunitinib-induced hypothyroidism is a common side-effect of the drug. There have been attempts to link hypothyroidism with a better clinical outcome in sunitinib-treated (mRCC) patients. Our ai...

Full description

Bibliographic Details
Main Authors: Theofanis Vasileiadis, Michail Chrisofos, Michail Safioleas, Konstantinos Kontzoglou, Konstantinos Papazisis, Athina Sdrolia
Format: Article
Language:English
Published: BMC 2019-04-01
Series:BMC Cancer
Subjects:
Sunitinib
Hypothyroidism
Metastatic renal cell cancer
Clear cell carcinoma
Thyroid-stimulating hormone
TSH
Online Access:http://link.springer.com/article/10.1186/s12885-019-5610-8

Internet

http://link.springer.com/article/10.1186/s12885-019-5610-8

Similar Items